Cargando…
Four cases of progressive multifocal leukoencephalopathy in iatrogenic immunocompromised patients
Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system (CNS) caused by John Cunningham Virus (JCV). We report four PML cases in immunocompromised patients, respectively treated with (1) Natalizumab, (2) Rituximab, (3) autologous stem-cell transplant...
Autores principales: | Bianchi, Alessia, Ragonese, Paolo, Banco, Maria Aurelia, Realmuto, Sabrina, Vazzoler, Giulia, Portera, Erika, La Tona, Giuseppe, Salemi, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248236/ https://www.ncbi.nlm.nih.gov/pubmed/32478179 http://dx.doi.org/10.1016/j.ensci.2020.100243 |
Ejemplares similares
-
Differences in Intercellular Communication During Clinical Relapse and Gadolinium-Enhanced MRI in Patients With Relapsing Remitting Multiple Sclerosis: A Study of the Composition of Extracellular Vesicles in Cerebrospinal Fluid
por: Geraci, Fabiana, et al.
Publicado: (2018) -
Association between multiple sclerosis, cancer risk, and immunosuppressant treatment: a cohort study
por: Ragonese, Paolo, et al.
Publicado: (2017) -
Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015) -
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers
por: Lo Re, Marianna, et al.
Publicado: (2015) -
Treatment of progressive multifocal leukoencephalopathy
por: Castle, Daniel, et al.
Publicado: (2019)